Arthritis develops when the protective structures inside a joint break down or come under attack, either from mechanical wear, an overactive immune system, or crystal deposits. It’s not a single disease but a group of over 100 conditions, and roughly 21% of U.S. adults have been diagnosed with some form of it. The three most common types, osteoarthritis, rheumatoid arthritis, and gout, each develop through fundamentally different biological pathways.
How Healthy Joints Work
Understanding what goes wrong starts with understanding what a healthy joint looks like. The ends of your bones are covered in smooth cartilage, a tough but flexible tissue made primarily of two components: collagen fibers that give it tensile strength, and a molecule called aggrecan that draws water into the tissue so it can resist compression. Think of cartilage as a spongy shock absorber that lets bones glide past each other without grinding.
Surrounding the joint is a thin membrane called the synovium, which produces synovial fluid. This fluid is rich in large molecules of hyaluronic acid, which give it a thick, viscous consistency, almost like egg whites. In a healthy joint, hyaluronic acid concentrations sit between 1 and 4 milligrams per milliliter, creating a low-friction, shock-absorbing layer that protects cartilage surfaces during movement. When any part of this system fails, the joint begins to deteriorate.
Osteoarthritis: Cartilage Wears Away
Osteoarthritis is the most common form and the one most people picture when they hear “arthritis.” It develops when cartilage gradually breaks down, and the process is more biochemically active than the old “wear and tear” label suggests. Your body is constantly rebuilding cartilage at a low level, but in osteoarthritis, destruction outpaces repair.
The breakdown follows a specific sequence. First, enzymes chew through the aggrecan molecules that hold water in cartilage. This is driven primarily by a family of enzymes that snip aggrecan at a critical point, releasing the water-attracting portion of the molecule and leaving the cartilage less able to cushion impacts. Only after aggrecan is stripped away does the collagen scaffold become vulnerable. Aggrecan essentially acts as a shield for collagen, so its loss is the first domino.
Once collagen is exposed, a second wave of enzymes attacks the collagen fibers directly. Collagen is one of the most stable proteins in the body, and very few enzymes can cut through it. In osteoarthritis, the primary culprit is an enzyme whose production ramps up dramatically in damaged cartilage. As collagen breaks apart, the cartilage thins, roughens, and eventually wears through entirely, leaving bone exposed against bone.
At the same time, the synovial fluid degrades. Inflammation and oxidative stress break down the large hyaluronic acid molecules into smaller fragments, reducing the fluid’s viscosity. The protective lubricating layer becomes thinner and less effective, increasing friction and accelerating cartilage damage in a self-reinforcing cycle.
How It Progresses Over Time
Osteoarthritis progresses through recognizable stages visible on X-rays. In the earliest phase, the joint looks mostly normal, with perhaps tiny bony projections (called osteophytes or bone spurs) forming at the joint edges. As it advances, the space between the bones visibly narrows as cartilage thins. In moderate stages, bone spurs become more prominent, and the bone beneath the cartilage starts to harden. In the most severe stage, the joint space is dramatically narrowed, large bone spurs are present, and the bone ends themselves become deformed. This progression can unfold over years or decades, and the rate varies enormously from person to person.
Rheumatoid Arthritis: The Immune System Attacks
Rheumatoid arthritis develops through an entirely different mechanism. It’s an autoimmune disease, meaning the immune system mistakenly identifies the body’s own joint tissue as a threat and mounts an attack against it.
The process begins when immune cells, both T cells and B cells, become directed against the body’s own proteins. One of the key triggers involves a chemical modification called citrullination, where the amino acid arginine in normal proteins gets converted to citrulline. This subtle change makes familiar proteins look foreign to the immune system. The proteins that get modified this way include components of cartilage, structural proteins in cells, and common enzymes. Interestingly, certain bacteria that cause gum disease can trigger this same protein modification, which may help explain why periodontal disease is linked to rheumatoid arthritis risk.
Once the immune system is activated against these modified proteins, it floods the synovial membrane with inflammatory cells. T cells infiltrate the synovium and release inflammatory signaling molecules, including tumor necrosis factor (TNF). B cells pile on by producing antibodies against the body’s own tissues, presenting more self-proteins to T cells, and releasing their own inflammatory signals. The concentration of inflammatory molecules like TNF, interleukin-1, and interleukin-6 rises sharply in the joint fluid, the synovium, and the bloodstream, and these levels track closely with disease severity.
The hallmark of rheumatoid arthritis is what happens next: the inflamed synovial membrane transforms into an aggressive, invasive tissue called pannus. New blood vessels sprout throughout the synovium to feed this growing tissue, and the pannus begins to creep over and into the cartilage surface. Joint destruction then proceeds through three simultaneous processes: the pannus directly invades cartilage, the cartilage cells themselves shift into a destructive mode where degradation enzymes overwhelm their natural inhibitors, and specialized bone-dissolving cells erode the underlying bone.
Morning Stiffness as an Early Signal
One of the earliest signs that distinguishes inflammatory arthritis from osteoarthritis is morning stiffness. Everyone with arthritis can feel stiff in the morning, but when that stiffness lasts longer than one hour, it’s a strong indicator that the underlying process is inflammatory rather than mechanical. Osteoarthritis stiffness typically eases within 15 to 30 minutes of moving around, while the prolonged stiffness of rheumatoid arthritis reflects the overnight accumulation of inflammatory fluid in affected joints.
Gout: Crystal Deposits in the Joint
Gout develops through a completely different pathway rooted in body chemistry rather than immune dysfunction or mechanical wear. It begins with elevated levels of uric acid in the blood, a condition called hyperuricemia. Uric acid is a normal byproduct of breaking down purines, compounds found in many foods and in your own cells. When blood uric acid rises above 6.8 milligrams per deciliter, it exceeds its saturation point and can begin to crystallize.
Crystal formation is a slow, stepwise process. Dissolved uric acid molecules first cluster together in the joint fluid, overcoming the forces that keep them dispersed. These clusters then aggregate into tiny crystal seeds, a rate-limiting step called nucleation. Once seed crystals exist, they grow into the characteristic needle-shaped structures that trigger gout attacks. The crystals have a layered architecture, with sheets of uric acid molecules stacked along a long axis, creating their distinctive sharp, elongated shape.
Several factors accelerate crystallization. Temperature plays a significant role: a drop of just 2 degrees Celsius, from normal body temperature to about 35°C, lowers the saturation threshold from 6.8 to 6.0 mg/dL. This is one reason gout so often strikes the big toe and other extremities, where tissue temperature runs cooler than the body’s core. Lower pH (more acidic conditions) also promotes crystal formation. Even physical impact on the joint can trigger nucleation, and cartilage components like chondroitin sulfate appear to accelerate crystal growth in laboratory studies.
When crystals form or shed into the joint space, the immune system treats them as foreign invaders, launching an intense inflammatory response. This is what causes the sudden, severe pain, swelling, and redness of a gout flare. Over time, repeated flares and persistent crystal deposits can cause permanent joint damage similar to other forms of arthritis.
Why Some People Develop Arthritis and Others Don’t
The risk of developing arthritis is shaped by a combination of genetics, body composition, prior injuries, and lifestyle. For rheumatoid arthritis, genetics play a particularly clear role. A specific set of gene variants creates a sequence of amino acids on immune cells known as the “shared epitope.” Carrying one copy of a shared epitope gene roughly doubles your odds of developing joint damage compared to someone without it (odds ratio of 2.38). Carrying two copies nearly quadruples the risk (odds ratio of 3.92). These same gene variants dramatically increase the likelihood of producing the antibodies against citrullinated proteins that drive the disease.
Other genetic factors contribute across arthritis types. Variants in genes that regulate immune signaling, inflammatory responses, and even the citrullination process itself have all been linked to increased risk. But genetics alone don’t determine who gets arthritis.
Obesity is one of the strongest modifiable risk factors, and its effects go beyond simply overloading weight-bearing joints. Fat tissue is an active endocrine organ that releases a class of signaling molecules that directly affect cartilage, bone, and immune cells. In obesity, the balance of these molecules shifts toward inflammation: pro-inflammatory varieties are overproduced while anti-inflammatory ones decline. Immune cells within fat tissue also shift toward a more inflammatory state, contributing to chronic low-grade inflammation throughout the body. This metabolic component explains a finding that initially puzzled researchers: obesity increases arthritis risk even in non-weight-bearing joints like the fingers, wrists, and jaw, where extra body weight places no additional mechanical stress.
Joint Injuries Set the Stage
A significant joint injury can set a person on the path toward arthritis years or even decades later. Post-traumatic arthritis accounts for a meaningful share of osteoarthritis cases, particularly in younger adults. After an injury that destabilizes a joint, such as a torn ACL, a dislocation, or damage to other stabilizing structures, the risk of developing osteoarthritis is roughly 9 to 12% within five years and 23% within ten years, even after surgical repair.
The injury sets off a cascade of changes: acute inflammation damages cartilage cells, the joint’s biomechanics shift as it heals, and the altered loading patterns accelerate the enzymatic breakdown processes described earlier. The joint may feel fine for years after surgery and rehabilitation, but the underlying cartilage deterioration continues quietly until symptoms eventually surface.